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Abstract 
 Alzheimer’s disease is a degenerative disease found in many aging adults.  The presence 
of amyloid precursor protein (APP) is an early indicator of the onset of Alzheimer’s, primarily in 
memory-related brain regions like the hippocampus.  Hormones accompanying pregnancy, such 
as estrogen, may provide the female brain with protection against neurodegeneration and 
deposits of APP.  The present study will compare concentrations of APP in the brains of parous 
and nulliparous animals and examine the interaction of APP with estrogen receptor beta (ER?).  
Young and aged animals will also be compared to determine any early effects of APP or ER?.    
It is proposed that because of the neuroprotective effects of preganacy, the parous animals will 
have lower concentrations of APP and higher concentrations of ER?.     
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Maternal Experience and Alzheimer’s Disease: 
Degenerative Differences in the Female Rat 
 Alzheimer’s disease is quickly becoming one of the most prevalent and devastating 
afflictions of today’s aging population.  Alzheimer’s disease is the fourth leading cause of death 
in Western nations, and it is estimated that approximately 24 million people worldwide suffer 
from Alzheimer’s-related dementia (Miller, McLoughlin, Kwok-Fai, Tennant, & Rogelj, 2006).  
There is no cure or effective treatment currently available for Alzheimer’s disease, but given its 
frequent occurrence in older adults, the need for treatment is becoming more and more 
pronounced.  In addition to seeking treatment for Alzheimer’s, scientists are still working to 
understand the intricate details of the complex pathology of this disease (Kar, Slowikowski, 
Westaway, & Mount, 2004). 
 Alzheimer’s disease is most distinctly characterized by neural plaques and neurofibrillary 
tangles, which both lead to eventual lesions in the brain, as well as a decrease in number of 
neurons and functional synaptic connections.  Therefore, neurons are unable to efficiently pass 
on messages, and cognitive functioning begins to decline (Stephan, Laroche, & Davis, 2001).  
The development of these degenerative features is linked to deposits of amyloid precursor 
protein (APP) in the brain, especially in regions associated with memory such as the 
hippocampus.  High concentrations of APP deposits are often found extremely early in the 
pathogenesis of the disease, even before specific Alzheimer’s symptoms emerge (Stephan, 
Laroche, & Davis, 2001).  Most notably, ?-amyloid peptide (A?) is derived from the APP 
deposits in the brain.  The A? acts as the core for the formation of neural plaques (Kar et al., 
2004). 
 The role of A? and APP in the pathogenesis of Alzheimer’s disease has been evaluated in 
many studies of animal models.  Stephan, Laroche, and Davis (2001) found that rats injected 
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with small amounts of A? experienced a significantly accelerated development of neural 
plaques.  The injected animals also performed poorly on cognitive tasks, made more behavioral 
mistakes in navigation, and made a greater number of errors on a working memory task than the 
non-injected control group.  These decreases in memory performance indicate that the presence 
of Alzheimer’s-related proteins in the brain lead to both negative behavioral modifications and 
disruptions in underlying neuroanatomy.    APP can have detrimental effects on the strength and 
speed of neuronal firing.  In a mouse model of Alzheimer’s, results indicated that hippocampal 
neurons lacking in APP had a higher frequency and strength of synaptic transmissions, and there 
were more functional neurons in the areas of the brain without APP (Priller, Bauer, Mitteregger, 
Krebs, Kretzschmar, & Herms, 2006). Once APP and A? effectively deposit the neural tangles 
and plaques, the target regions of the brain start to lose neurons and functional synapses, 
resulting in the beginnings of the slow cognitive degeneration associated with Alzheimer’s 
disease (Kar et al., 2004).  
Sex Differences and Hormones 
 Alzheimer’s disease is more prevalent in women than in men.  This sex difference can be 
attributed to an overall longer female lifespan and differences in the duration of the disease; 
women with Alzheimer’s tend to live longer with the disease than men (Baum, 2005).  The body 
may also provide some natural defenses against the effects of Alzheimer’s.  Specifically, 
hormones may play a mediating role in the development and progression of the disease.  It has 
been suggested that testosterone may protect men from Alzheimer’s disease, while estrogen may 
have similar protective effects for women (Baum, 2005). 
 Studies on hormone replacement therapy have confirmed the beneficial effects of female 
hormones like estrogen on the pathogenesis of Alzheimer’s disease.  Henderson, Benke, and 
Greene (2005) found that a hormone therapy regimen including estrogen might reduce the risk of 
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developing early onset Alzheimer’s.  It was also concluded that the hormone therapy must be 
administered at a certain critical time period, during the early stages of postmenopausal 
symptoms, for protective effects against Alzheimer’s to be executed.  Beginning a hormone 
therapy regimen years after the onset of menopause and the loss of endogenous estrogen is too 
late, and the beneficial effects that result from earlier hormone administration will not occur 
(Baum, 2005).  Generally, hormone replacement therapy exhibits a ‘healthy cell bias,’ in which 
neurons that are healthy during administration will experience the benefits of therapy, while 
hormones will cause further damage in unhealthy neurons (Brann, Dhandapani, Wakade, 
Mahesh, & Khan, 2007).   It is also important to consider dosage when administering hormone 
replacement therapy.  Baum (2005) reported an inverted U-shaped pattern in the effectiveness of 
hormone dosages; a small dosage did not show any effects and a large dosage could have toxic 
and harmful effects.  An excessive administration of exogenous estrogen can disrupt the body’s 
natural fluctuations of hormones, which can actually have detrimental effects on the functioning 
of the brain (Marriott & Wenk, 2004).  Moderate amounts of hormone replacement therapy that 
more closely mimic the body’s natural cycle may provide the best protection against the 
degeneration of Alzheimer’s disease (Marriott & Wenk, 2004). 
The Role of Estrogen Receptors   
Estrogen is a female reproductive hormone, traditionally associated with gender 
differentiation during the developmental period and increased synaptic plasticity during puberty 
and the ovarian cycle.  More recently, estrogen has been implicated in playing a role in vital 
actions of the brain, including the release of neurotransmitters, electrical excitability, and 
synaptic function (Genazzani, Pluchino, Luisi, & Luisi, 2007).   The positive role of estrogen in 
neuroaction has made it a focus of recent research on the prevention of neurodegenerative 
diseases.  Estrogen depletion in the aging brain may be an early risk factor for Alzheimer’s 
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disease, and a continued presence of estrogen in the brain may preserve specific areas in the 
brain targeted by disease pathology (Brann et al., 2007).  Although estrogen-based hormone 
replacement therapy has been linked to reduced risk of Alzheimer’s onset, the side effects have 
made the therapy controversial.  The actions of the therapy are beneficial in the brain, but can 
have detrimental impacts on peripheral tissues, including an increased risk of breast and uterine 
cancer (Carroll & Pike, in press).  Because of these harmful effects, research on estrogen 
therapies has focused on making treatments more specific to the areas of the brain associated 
with neurodegeneration. 
One target-specific focus of research has involved the differentiation between two 
different estrogen receptors: estrogen receptor alpha (ER?) and estrogen receptor beta (ER?).  
Both receptors have been linked to neuroprotection in the brain, especially in learning and 
memory-related areas (Genazzani et al., 2007).  ER? and ER? are both present in the 
hippocampus, and deposits of Alzheimer’s-related proteins are regulated through each of these 
receptors (Brann et al., 2007).  However, the different mechanisms of ER? and ER? are not fully 
understood.  Overall, the actions of estraidol, a clinical form of estrogen, are found to be 
predominantly dependent on ER?, indicating that it is the primary estrogen receptor (Carroll & 
Pike, in press).   
Research has shown that ER?, a more recently discovered receptor, might also play a 
primary role in estrogen regulation in the brain, especially in association with Alzheimer’s 
pathology.  ER? is closely associated with learning and memory because it is the predominant 
type of estrogen receptor found in the hippocampus (Genazzani et al., 2007).  Because of its 
increased presence in the hippocampus, hormone therapy that is ER? specific might have 
especially beneficial effects in the brain (Wang, Irwin, & Brinton, 2006).  Research by Forsell, 
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Enmark, Axelman, Blomberg, Wahlund, Gustafsson, et al. (2001) further linked ER? and 
Alzheimer’s by confirming that a mutation in the ER? gene might increase susceptibility to 
Alzheimer’s disease.  Given this recent research on its presence in the hippocampus and 
association with Alzheimer’s disease, the present study will focus on the expression of ER? in 
the brain.              
Maternal Experience 
 The benefits of the natural hormonal changes associated with the female reproductive 
experience are well established.  Motherhood leads to improvements in learning and memory, 
both of which are functions of the hippocampus.  Oxytocin, another hormone associated with 
reproduction, also enhances neural functioning and potentiation of neural messages (Pawluski, 
Walker, & Glaea, 2006).  Pregnant female rats demonstrated better performance on tests of 
spatial memory than virgin rats, which can be attributed to the elevated and relatively stable 
levels of estrogen present in the body during pregnancy (Galea, Ormerod, Sampath, Kostaras, 
Wilkie, & Phelps, 2000).  Galea et al. (2000) also established that pregnant rats spent more time 
in the target quadrant of the water maze and traveled shorter distances to the reward than 
nonpregnant animals, demonstrating the positive effects of pregnancy on learning and memory.   
 In addition to hormonal changes, maternal animals must respond to a large number of 
novel stimuli as a result of exposure to pups.  Suddenly, new mothers find that they are 
responsible for the survival of their offspring (Love, Torrey, Glasper, DeVries, Lambert, & 
Kinsley, 2005).  They must quickly acquire new skills, such as improving their hunting abilities, 
so that they can obtain food for themselves as well as their new pups.  New mothers must learn 
to forage and recall the spatial location of food in an effort to spend less time away from their 
offspring (Love et al., 2005).  The first pregnancy is therefore critical, as the female brain begins 
to change in response to new hormone levels and a range of sensory stimuli from the pups.  The 
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maternal rat must make her own modifications and obtain new skills to ensure the survival of her 
offspring, without any previous experience or knowledge in this area (Pawluski et al., 2006).  
Subsequent pregnancies can increase the benefits of initial hormone and pup exposure.  While 
primiparous (single reproduction) animals outperformed nulliparous (no reproduction) animals 
on tests of learning and memory, multiparous (more than one reproduction) animals often 
performed better than both groups (Gatewood, Morgan, Eaton, McNamara, Stevens, & Kinsley, 
2005).  Therefore, repeated exposure to reproductive hormones and offspring can lead to a 
further enhancement in neural functioning and memory.         
 The present study looks to extend the findings of Gatewood et al. (2005) that the paired 
exposure to both pups and the natural hormonal changes of the female reproductive experience 
preserves the aging brain from degeneration and provides neuroprotection against memory 
declines.  Parous animals have lower levels of amyloid precursor protein in their brains, and 
multiparous animals have significantly less of the protein deposited in their brains than 
primiparous animals (Gatewood, 2005).  These results suggest that the protection provided by 
maternal experience can extend specifically to defense against the risks of Alzheimer’s disease.  
Given that the results of hormone replacement studies have supported the benefits of moderate 
dosages that mimic the actual female hormone cycle, it is possible that the natural exposure to 
female reproductive hormones provides an effective barrier against the onset of Alzheimer’s, 
even at a relatively young age (Marriott & Wenk, 2004).  It is also possible that moderate 
dosages of hormone replacement therapy and natural reproductive hormone levels have equally 
beneficial effects (Love et al., 2005). 
 A preliminary study in female rats did indicate higher concentrations of APP in 
nulliparous animals than primiparous animals, which were aligned with the findings of previous 
research (Gatewood et al., 2005).  An immunofluorescent investigation of the expression of APP 
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in the female hippocampus showed that primiparous animals had a lower concentration of APP 
in the hippocampal region of their brains than age-matched nulliparous animals.  While it is 
expected that maternal experience will offer some protection against the onset of 
neurodegeneration, the present study looks to specifically examine the expression of ER? in the 
female rat brain.  An understanding of how the deposits of ER? and APP interact and are 
expressed together can give some further indication to the specific protective mechanisms of 
pregnancy hormones in the brain. 
 The current study will expand upon past findings investigating the early signs of 
neurodegeneration in younger rats.  While past research has focused on the presence of 
Alzheimer’s-related declines in aged animals, more research in younger animal models will 
indicate the effects of APP and memory decline early in life.  Priller et al. (2006) found that in 
animals lacking APP, the enhancements of neuron and synapse functioning were more 
pronounced in young mice, aged three weeks, than older mice, aged 11 months.  Studies 
involving the administration of degenerative protein have also supported their quick and early 
action.  In animals injected with A?, collections of amyloid protein and neuron loss were seen 
around injection sites in as little as seven weeks (Stephan et al., 2001).  Given the support of 
early administration of therapeutic remedies like hormone replacement therapy, it is important to 
identify the early progression of the disease to effectively stop the first signs of Alzheimer’s 
pathology.   
 The present study will investigate the effects of maternal experience, its accompanying 
hormones, and its novel stimuli on the emergence of neuroanatomical changes related to 
Alzheimer’s disease in young and old female rats.  It is expected that our findings will replicate 
past research that deposits of APP increase with age, while the presence of estrogen receptors 
decrease with age (Priller et al., 2006; Brann et al., 2007).  It is expected that these neural 
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differences will be seen predominantly in the hippocampus, a region of the brain essential for 
memory.  Specifically, the current study will focus its investigation on the CA1 region of the 
hippocampus, an area of neural density and a high concentration of ER? receptors (Carroll & 
Pike, in press).  
Hypotheses    
1. It is hypothesized that primiparous animals will have less APP than nulliparous animals, as 
measured by the area of APP expression.   
2. It is hypothesized that younger animals will have less APP than older animals, as measured by 
the area of APP expression. 
2a.  It is hypothesized that old primiparous animals will have less APP than old nulliparous 
animals. 
2b. It is hypothesized that old primiparous animals will have more APP than young 
primiparous and young nulliparous animals. 
2c. It is hypothesized that old nulliparous animals will have more APP than young 
primiparous and young nulliparous animals. 
2d.  It is hypothesized that young primiparous animals will have less APP than young 
nulliparous animals. 
3. It is hypothesized that primiparous animals will have more ER? than nulliparous animals, as 
measured by the area of ER? expression.   
4. It is hypothesized that younger animals will have more ER? than older animals, as measured 
by the area of ER? expression.   
4a.  It is hypothesized that old primiparous animals will have more ER? than old nulliparous 
animals. 
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4b. It is hypothesized that old primiparous animals will have less ER? than young primiparous 
and young nulliparous animals. 
4c. It is hypothesized that old nulliparous animals will have less ER? than young primiparous 
and young nulliparous animals. 
4c.  It is hypothesized that young primiparous animals will have more ER? than young 
nulliparous animals. 
Method 
Animals 
 The animals used in the present study were six female rats, and they were ordered from 
Zivic-Miller Laboratories, Inc.  The animals were housed in the University of Richmond Animal 
Facility.  Each animal was housed individually in a 25 cm ? 40 cm ? 25 cm cage with corncob 
bedding, and food and water was available ad libitum in the home cage.  The animals differed 
only in their ages and reproductive experience.  Two of the rats were 12 months of age at the 
time of perfusion, and four of the animals were four months of age at the time of perfusion.  The 
older animals were perfused at the age of approximately 12 months because it is a time when 
potentially degenerative neuroanatomy is expected to be observed, yet the animals have not fully 
reached old age (Gatewood et al., 2005).  The younger animals were perfused at the age of four 
months because it is an early time in the developmental period of the rat when early signs of 
neurodegeneration are expected to emerge (Priller et al., 2006).  Of the older rats, one was a 
primiparous animal (having one pregnancy) and the other was a nulliparous animal (having no 
pregnancies).  Two of the younger rats were primiparous, while the other two were nulliparous.    
The older parous animal was given a 21-day postpartum experience with her offspring before the 
pups were weaned, and the younger parous animals were given a 14-day postpartum experience.   
The parous and nulliparous animals were exposed to identical living conditions, and the home 
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cages of all of the animals were housed in the same room so as to be exposed to the same light 
and dark schedule. 
Tissue Preparation 
 The animals were exposed to carbon dioxide gas and sacrificed by an overdose of sodium 
pentobarbital.  The animals were then perfused with both PBS and 4% paraformaldehyde (PF), 
and their brains were surgically removed.  The dissected brains were immersed in PF for 
approximately five hours, and then switched to a solution of 30% PBS sucrose for two days.  The 
sucrose was switched after the first day. 
 The brains were sectioned for the area of interest, the anterior region of the hippocampus, 
with the aid of an atlas (Paxinos & Watson, 1998).  That section of the brain was then sliced by a 
cryostat set at -18 °C into sections that were 40 ? in thickness.  Approximately 48 slices were cut 
for each animal, and placed in groups of four into 12-well culture dishes filled with TBS.  After 
several initial TBS washes, the sections were immersed in a primary antibody cocktail overnight 
at 4 °C.  The primary antibody cocktail was composed of a rabbit anti-amyloid precursor protein 
polyclonal antibody (Invitrogen 51-2700) and a goat anti-ER? polyclonal antibody (Santa Cruz 
Biotechnology sc-6821).  The anti-APP primary antibody was used at a dilution of 1:500 (2 
?g/ml), and the anti-ER? primary antibody was used at a dilution of 1:200 (5 ?g/ml).  As a 
negative control measure to check for nonspecific staining, two wells per tray were not exposed 
to the overnight primary antibody incubation, although all of the other steps of the protocol were 
followed for these tissue sections.  The second day, after more TBS washes, the sections were 
immersed in the secondary antibody cocktail for two hours at 4 °C.  The secondary cocktail was 
compiled of a goat anti-rabbit Alexa Fluor 488 secondary antibody (Invitrogen A11070) and a 
rabbit anti-goat Alexa Fluor 594 secondary antibody (Invitrogen A21223).  Both secondary 
antibodies were used at a dilution of 1:400 (2.5 ?g/ml).  During the secondary antibody wash, the 
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culture trays were covered in aluminum foil to prevent exposure of the sensitive fluorescent 
antibodies to light.  (see Appendix A for immunofluorescent protocol). 
 After the completion of staining, the tissue sections were mounted onto gelatin subbed 
slides and allowed to dry overnight. The slides were covered in foil to minimize light exposure.  
Once they were dry, the sections were coverslipped with Prolong Gold antifade reagent with 
DAPI (Invitrogen P36935).  Prolong Gold preserves the tissue and fluorescent signal, while the 
DAPI is used as a marker of cell bodies because it binds to nuclear chromosomes and emits a 
blue fluorescent stain of DNA (Invitrogen, 2008). 
Tissue Analysis 
 The tissue sections were analyzed with a Zeiss Imager.Z1 microscope.  The program 
AxioVision (release 4.6.1) was also used to analyze images and quantify protein expression in 
the tissue sections.  The CA1 of the hippocampus was initially identified at 5? magnification, 
and an image of the CA1 for each tissue section was captured at 40? magnification.  Each image 
captured a 220.4 ?m ? 170 ?m portion of the CA1.   A merged image of multiple fluorescent 
channels was captured to show the combined presence of the green APP fluorescence, the red 
ER? fluorescence, and the blue DAPI fluorescence (see Figures B1-F1). 
 As part of the AxioVision software, Program Wizard was used to quantify the area of 
APP and ER? fluorescent expression in each tissue section.  First, the merged images were 
separated, and the green APP stain and red ER? stain were quantified separately.  The program 
selected areas of cell bodies expressing an optimal amount of fluorescent stain and calculated the 
total summed area of the amount of stain per image.  The areas of expression were calculated in 
?m2, and the means of APP and ER? expression were calculated for each animal. 
Results 
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Amyloid Precursor Protein Analysis 
 Primiparous animals had less APP expression (M = 2069.76 ?m2, SD = 1623.86) than 
nulliparous animals (M = 4236.30 ?m2, SD = 1229.70).  An one-way ANOVA was run and did 
not indicate a significant difference, F(1,4) = 3.39, p = 0.14 (see Table H1). 
 Young animals had less APP expression (M = 2372.65 ?m2, SD = 1510.64) than older 
animals (M = 4713.79 ?m2, SD = 1088.58).  An one-way ANOVA was run and did not indicate a 
significant difference F(1,4) = 3.64, p = 0.13 (see Table I1). 
 To further determine differences in APP expression, a 2 ? 2 between-subjects ANOVA 
was run.  The old primiparous animal had more APP expression (M = 3944.04 ?m2, SD = 0.00) 
than the young primiparous animals (M = 1132.62 ?m2, SD = 66.77).  The old nulliparous animal 
also had more APP expression (M = 5483.53 ?m2, SD = 0.00) than the young nulliparous animal 
(M = 3612.68 ?m2, SD = 831.22).  A significant main effect of age was found, F(1,2) = 21.02, p 
< 0.05, and a marginally significant main effect of maternal experience was found, F(1, 2) = 
15.49, p = 0.06.  There was not a significant interaction of age and maternal experience, F(1,2) = 
0.85, p = 0.45 (see Table J1). 
Estrogen Receptor Beta Analysis 
Primiparous animals had more ER? expression (M = 1200.47 ?m2, SD = 656.96) than 
nulliparous animals (M = 331.80 ?m2, SD = 215.19).  An one-way ANOVA was run and did 
indicate a significant difference, F(1,4) = 10.10, p < 0.05 (see Table K1). 
 Young animals had less ER? expression (M = 719.90 ?m2, SD = 584.06) than older 
animals (M = 1458.61 ?m2, SD = 1272.43).  An one-way ANOVA was run and did not indicate a 
significant difference F(1,4) = 1.10, p = 0.35 (see Table L1). 
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 To further determine differences in ER? expression, a 2 ? 2 between-subjects ANOVA 
was run.  The old primiparous animal had more ER? expression (M = 2358.35 ?m2, SD = 0.00) 
than the young primiparous animals (M = 1221.53 ?m2, SD = 40.04).  The old nulliparous animal 
also had more ER? expression (M = 558.86 ?m2, SD = 0.00) than the young nulliparous animal 
(M = 218.28 ?m2, SD = 123.61).  A significant main effect of age was found, F(1,2) = 86.19, p < 
0.05, and a significant main effect of maternal experience was found, F(1, 2) = 310.19, p < 0.05.  
There was also a significant interaction of age and maternal experience, F(1,2) = 25.04, p < 0.05 
(see Table M1). 
Discussion 
 The present study supported the hypothesis that primiparous animals would have 
significantly higher levels of ER? expression than nulliparous animals.  The hypothesis that 
primiparous animals would have less APP than nulliparous animals was not supported.  Also, the 
hypotheses that younger animals would have less APP than older animals and that younger 
animals would have more ER? than older animals were not supported.  However, there was a 
main effect of age on APP expression and main effects of age and maternal experience on ER? 
expression.  Finally, an interaction of age and maternal experience on ER? expression was also 
established.   These trends in the data might have interesting implications for the study of 
Alzheimer’s disease and potential therapeutic targets. 
 One of the most interesting trends in the data was that primiparous animals did have 
lower mean levels of APP expression in the CA1 of the hippocampus than nulliparous animals.  
These findings indicate that maternal experience might offer some protection against the 
depositing of APP in the brain.  Since the present study investigated only naturally-occurring, 
baseline levels of APP and ER?, these results support past findings that moderate dosages of 
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hormone replacement therapy that mimic the body’s natural levels might have the best 
neuroprotective effects (Marriott & Wenk, 2004).  However, it is important to note that there was 
not an overall significant difference in APP expression between parous and nulliparous animals.  
While pregnancy hormones might offer some neurprotection, the results of the present study 
indicate that there are other factors influencing the pathogenesis of Alzheimer’s.  Hormone 
replacement therapy might not be the best treatment option in all cases.  Potential detrimental 
effects of hormone replacement therapy have been established and were laid forth in the 
Women’s Health Initiative Study, including an increased risk of dementia and cancer in 
peripheral tissues (Baum, 2005). 
 The present study did find a significant difference in the expression of ER?.  Primiparous 
animals had more ER? than nulliparous animals.  The combined presence of ER? and APP in the 
tissue sections examined indicates that ER? might have a role in offering neuroprotection.  
However, more research needs to be completed on the specific mechanisms of ER?, especially in 
contrast to what is known about the mechanisms of ER?.  It is possible that one type of receptor 
offers a higher degree of neuroprotection than the other type.  Therapies that specifically target 
the most beneficial receptor type could be particularly effective in refining the actions of 
hormone replacement therapy and combating the onset of Alzheimer’s disease (Carroll & Pike, 
in press). 
 Another interesting trend in the present study was the age differences found in measured 
area of APP expression.  Higher mean areas of APP were found in older animals.  There was a 
significant main effect of age and APP expression, but the overall age difference was not found 
to be statistically significant, indicating that there was also a presence of APP in the hippocampal 
regions of the younger animals.  This finding supports past research that the onset of Alzheimer’s 
 Maternal Experience     17
disease symptoms can begin relatively early in the lifespan, and that the effects of the changes in 
neuroanatomy can begin to take their toll at a young age (Stephan et al., 2001).   
 The trend seen in age differences in ER? expression was also found, although this trend 
opposed the proposed hypothesis.  Overall, younger animals had lower means of ER? expression 
than older animals, and a significant main effect of maternal experience and ER? expression was 
established.  These results do not support past findings of a decline in estrogen receptor 
expression with age (Brann et al., 2007).  In contrast, the present results suggest that ER? levels 
might remain relatively stable or even increase across the lifespan.  These findings have 
implications in considering dosage levels for hormone replacement administration, especially in 
older women.  In order to maintain an effective moderate dose, the changes in baseline hormone 
levels that come with age need to be further understood. 
 It is important to note that the trend of more expression of ER? may be attributed to the 
fact that the older and younger primiparous animals had differing lengths of postpartum periods 
with their offspring.  Post-pregnancy events, including sensory exposure to pups and lactation, 
have been found to contribute to the increased neural plasticity accompanying motherhood, 
above and beyond the effects of the pregnancy hormones alone (Love et al., 2005).  Since the 
older animals had a longer postpartum period with their pups, it is possible that the additional 
week of offspring sensory exposure led to further neuroanatomical changes and allowed them to 
maintain higher levels of ER? expression. 
 A primary limitation of the present study is the small sample size.  Only six animals were 
investigated, and the older age group only consisted of two animals.  It would be important to 
replicate the current findings with a larger sample of animals.  Another limitation in the present 
study was the limited area of the brain examined.  While the CA1 of the hippocampus has been 
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found to be essential for memory related-processes, in addition to being a main target of 
Alzheimer’s pathogenesis, it is possible that other areas of the brain play an equally important 
role in the progression of the disease.  It would be interesting to study other areas of the brain 
linked to learning and memory, such as the amygdala, or even other regions within the 
hippocampus.  For example, the dentate gyrus has also been found to be a site of high neural 
density and protein expression that might also be a target of Alzheimer’s pathogenesis 
(Gatewood et al., 2005). 
 Future research could expand upon the present study by including a behavioral task, in 
addition to brain analysis.  Studies have indicated that overall, parous animals outperform 
nulliparous animals on learning and memory-related tasks (Love et al., 2005; Galea et al., 2000; 
Pawluski et al., 2006).  Additionally, animal models injected with APP have demonstrated 
decreased performances in working-memory tasks (Stephan et al., 2001).  It would be interesting 
to include a behavioral component to investigate the combined effects of maternal experience as 
well as Alzheimer’s-related protein deposits in the brain on behavioral performance.  This 
research would result in a further connection between behavioral performance and underlying 
neuroanatomical structure. 
 The findings of the present study have implications for the further study of Alzheimer’s 
disease pathology and potential sites of therapeutic action.  The present findings indicate a 
complex and dynamic interaction between deposits of APP and the presence of ER?.  This 
relationship that is seen in even natural, baseline levels indicates the further complications that 
can be brought on by additional hormone administration.  Future research needs to be continued 
to find sites of action and optimal doses for exposure to exogenous estrogen.  An effective 
administration of hormones would result in neuroprotection against the onset of degenerative 
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proteins, without making the body susceptible to potentially the potentially detrimental effects of 
too much hormone exposure. 
 Finally, the present study has implications for the elucidation of the complex aspects of 
Alzheimer’s pathology.  Specifically, the results indicate that the disease might have a unique 
and specific progression in the female brain because of the differential effects of sex hormones 
on neuroanatomy.  Since Alzheimer’s disease is more prevalent in women, it is important to 
further understand the particular ways in which the pathogenesis of the disease attacks the female 
brain.  Further understanding of the actions of Alzheimer’s in the brain and the protective impact 
of female hormones might introduce novel sites of therapeutic action that could moderate the 
devastation of this neurodegenerative disease.    
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Appendix A 
Immunofluorescent Staining Protocol 
TBS (1L) 
900 ml dH20 
6.05 g Tris base 
9 g NaCl 
 
TBS ++ (500 ml) 
15 ml 3% normal goat serum 
1.25 ml 10% Triton 
500 ml TBS 
 
Staining: Day One 
5 min TBS 
5 min TBS 
5 min TBS 
 
60 min TBS ++ 
 
Overnight in 1º Ab diluted in TBS++ (keep at 4 ºC) 
 
Staining: Day Two 
15 min TBS 
15 min TBS 
 
15 min TBS++ 
 
***The rest of the steps should be done with absolute minimal exposure to light 
 
120 min 2º Ab diluted in TBS ++ (keep at 4 ºC) 
 
5 min TBS 
5 min TBS 
 
Tissue Preparation: Day Three 
Allow mounted slides to dry overnight, then coverslip with Prolong Gold with DAPI 
 
***Allow coverslipped slides to dry for three-five days before placing in a slide box 
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Appendix B 
 
Figure B1 
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Appendix C 
Figure C1 
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Appendix D 
Figure D1 
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Appendix E 
Figure E1 
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Appendix F 
Figure F1 
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Appendix G 
Figure Captions 
Figure B1.  Preliminary immunofluorescent stain for amyloid precursor protein (green) and 
DAPI (blue) in CA1 of an old primiparous animal, 40? magnification. 
Figure C1.  Immunofluorescent stain for amyloid precursor protein (green), estrogen receptor-
beta (red), and DAPI (blue) in CA1 of an old primiparous animal, 40? magnification. 
Figure D1.  Immunofluorescent stain for amyloid precursor protein (green), estrogen receptor-
beta (red), and DAPI (blue) in CA1 of an old nulliparous animal, 40? magnification. 
Figure E1.  Immunofluorescent stain for amyloid precursor protein (green), estrogen receptor-
beta (red), and DAPI (blue) in CA1 of a young primiparous animal, 40? magnification. 
Figure F1.  Immunofluorescent stain for amyloid precursor protein (green), estrogen receptor-
beta (red), and DAPI (blue) in CA1 of a young nulliparous animal, 40? magnification. 
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Appendix H 
Table H1 
Mean Levels of Amyloid Precursor Protein Expression in Animals with Different Maternal 
Experience 
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Appendix I 
 
Table I1 
Mean Levels of Amyloid Precursor Protein Expression in Animals from Different Age Groups 
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Appendix J 
Table J1 
Mean Levels of Amyloid Precursor Protein Expression in Animals from Different Age Groups 
with Different Maternal Experience 
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* indicates a significant main effect of age at the 0.05 level 
** indicates a marginally significant effect of maternal experience 
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Appendix K 
 
Table K1 
Mean Levels of Estrogen Receptor Beta Expression in Animals with Different Maternal 
Experience 
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*indicates a significant difference at the 0.05 level 
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Appendix L 
Table L1 
Mean Levels of Estrogen Receptor Beta Expression in Animals from Different Age Groups 
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Appendix M 
Table M1 
Mean Levels of Estrogen Receptor Beta Expression in Animals from Different Age Groups with 
Different Maternal Experience 
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* indicates a significant main effect of age at the 0.05 level 
** indicates a significant effect of maternal experience at the 0.05 
***indicates a significant interaction of age and maternal experience at the 0.05 level 
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